NOVI Multi-Cancer Early Detection

Get Access to Comprehensive Cancer Screening

Screen for up to 50 Cancers
in a Single Blood Test

Why Choose LucenceINSIGHT™ for Your Peace of Mind?
Traditional screening methods often focus on one or a few cancers at a time. LucenceINSIGHT™ offers a more comprehensive and convenient solution.

Unprecedented Scope in a Single Test

Instead of multiple procedures, a single blood draw is all it takes to screen for up to 50 different types of cancer. This broad screening capability is especially vital considering that 78% of cancer deaths occur in cancers not commonly screened for.

Harnessing Science using the ctDNA Technology

LucenceINSIGHT™ detects circulating tumor DNA (ctDNA). These are tiny fragments of DNA released into the bloodstream by cancer cells. By identifying these specific "cancer signals," we can detect potential cancers early, often before symptoms even appear.

High Accuracy You Can Trust

We understand that accuracy is paramount. LucenceINSIGHT™ offers a high sensitivity of 80.9% (correctly identifying cancer when present) and a remarkable specificity of 99.2% (correctly identifying when cancer is not present), providing you with reliable insights.

Simple, Convenient, and Non-Invasive

LucenceINSIGHT™ is a multi-cancer early detection (MCED) test that screens for the circulating tumor DNA (ctDNA) of up to 50 cancers in one simple blood draw.

Empowering Early Action

Early detection is the most powerful weapon against cancer. By identifying potential cancers sooner, LucenceINSIGHT™ provides you and your doctor with the critical advantage of time, enabling more effective and often less invasive treatment options.

预约

Which Multi-Cancer Early Detection test (MCED) is right for you?

LucenceINSIGHT™ screens for the risk of cancer with a sensitivity of 80.9%, which means that it has an 80.9% chance to correctly detect cases of the particular disease in question. It also has a specificity of 99.2%, which means that it can correctly identify when a person being tested does not have the disease 99.2% of the time.

LucenceINSIGHT™ 5

5 types of cancer

$999

Inclusive of GST

This is a blood test that screens for the risk of
5 types of cancer:

  • Lung
  • 甲状腺
  • 肝脏
  • Pancreatic
  • Colorectal cancer

LucenceINSIGHT™ 7

7 types of cancer – For women

$1,299

Inclusive of GST

This is a blood test for women that screens for the risk of
7 types of cancer:

  • Lung
  • 甲状腺
  • 肝脏
  • Pancreatic
  • Colorectal
  • Breast
  • Ovarian cancer

LucenceINSIGHT™ 12

12 types of cancer in men and women

$1,939

Inclusive of GST

This is a blood test that screens for the risk of 12 types of cancer:

For everyone:
Nasopharyngeal, Thyroid, Lung, Liver, Stomach, Pancreatic, Gastrointestinal stromal tumor (GIST), Colorectal

For men:
Esophageal, Kidney (clear cell), Bladder and Prostate cancer.

For women:
Breast, Ovarian, Cervical, and Endometrial cancer.

最受欢迎

LucenceINSIGHT™ 50

50 types of cancer – For those 40+ or at higher cancer risk (e.g., strong family history)

$3,800

Inclusive of GST

LucenceINSIGHT™ 50 screens for 50 cancer types, including two types of leukemia as well as a common age-related bone marrow phenomenon associated with an increased risk of developing cardiovascular disease and hematologic cancers.

View the full list of cancers here.

价格

Test Price (inclusive of GST)

Doctor consultation (for pre and post review)

$54.50

LucenceINSIGHT™ 5

$999

LucenceINSIGHT™ 7 (for Women)

$1,299

LucenceINSIGHT™ 12

$1,939

LucenceINSIGHT™ 50

$3,800

Prices are inclusive of GST. Prices above apply if the LucenceINSIGHT™ test is done as part of health screening or as an addition to other NOVI services. If you choose a standalone Multi-Cancer Early Detection (MCED) test, a doctor consultation fee of $54.50 is applicable.

立即预约

How It Works:
A Simple Path to
Powerful Insights

We've streamlined the process to make cancer screening accessible.

立即预约

  • Consult Your Doctor

    Begin with a consultation where our doctor will assess your individual health profile, discuss any risk factors, and determine if LucenceINSIGHT™ is right for you. Consultation can be done in the clinic or online.

  • Simple Blood Draw

    A quick and easy blood sample is collected at our clinic.

  • Advanced Laboratory Analysis

    Your sample is sent to the laboratory, where the blood sample is analyzed for ctDNA signals associated with up to 50 different cancers.

  • Clear Results & Expert Review

    Once your results are ready (indicating whether cancer signals were "Detected" or "Not Detected"), you'll have a follow-up consultation with your doctor. They will explain your results thoroughly and discuss any recommended next steps.

Your Medical Team

Sue Anne Toh 博士

内分泌学高级顾问专家

硕士，MBBChir（英国剑桥大学），ABIM（国际医学，内分泌学）

Kyle Tan 博士

预防医学顾问

理学硕士、医学博士、法学硕士

陶德安博士

副顾问，家庭医生

医学理学士，医学博士，医学硕士（FM），医学哲学博士（S）

杨俊杰博士

家庭医生

MD, GDFM

View Full Profiles

常见问题

  • How does LucenceINSIGHT™ cancer screening work?

    LucenceINSIGHT™ is a comprehensive test that can screen for up to 50 cancers in one blood draw. It works by picking up cancer-related changes in circulating DNA fragments, known as circulating tumor DNA (ctDNA), that are released by cancer cells into the bloodstream. Your results will show whether any of these “cancer signals” were found (“Detected”) or not (“Not Detected”), helping you and your doctor decide if any follow-up is needed.

  • How accurate is LucenceINSIGHT™ cancer screening?

    LucenceINSIGHT™ screens for the risk of cancer with a sensitivity of 80.9%. This means that it has an 80.9% chance to correctly detect cases of the particular disease in question. It also has a specificity of 99.2%, which means that it can correctly identify when a person being tested does not have the disease 99.2% of the time.

  • Who is LucenceINSIGHT™ cancer screening recommended for?

    LucenceINSIGHT™ is designed to complement your regular health screenings and is recommended for:


    • Adults aged 40 and above with no personal history of cancer
    • Individuals at higher risk of cancer, for example, those with a family history, or certain lifestyle and dietary factors

    Please note: This test isn’t recommended if you’re currently pregnant or if you’ve had cancer within the past 3 years.

  • How LucenceINSIGHT™ give a clearer picture compared to tumor marker tests?

    Traditional tumor marker tests (e.g., CA19-9, CA-125) measure specific proteins that can be elevated by cancer cells, but this is not always the case. LucenceINSIGHT™ works differently and offers distinct advantages:


    • Detecting the Source Code: LucenceINSIGHT™ looks for changes directly in your DNA (the ctDNA shed by tumors). These genetic alterations are often the root cause of cancer development.
    • Broader Detection Capabilities: Traditional markers are typically specific to one cancer type. LucenceINSIGHT™ screens for a much wider range of cancers simultaneously.
    • Earlier Signals: ctDNA can sometimes be detected earlier than elevated protein markers, potentially offering an earlier window for detection and are more accurate.

    By combining the power of ctDNA detection with expert medical guidance, LucenceINSIGHT™ provides a more comprehensive view of your cancer risk, offering you a new level of proactive health management.

  • How often should LucenceINSIGHT™ cancer screening be done?

    It is recommended to go for cancer screenings annually. Regular annual screenings help catch cancer early, when it’s most treatable, allowing you and your healthcare provider to keep an eye on any changes in your health over time. However, the right screening schedule can vary from person to person, so we’ll tailor it based on your unique risk factors and medical history.

  • How soon can I expect to receive my LucenceINSIGHT™ cancer screening results?

    Turnaround time depends on the panel selected:


    • LucenceINSIGHT™ 5, 7, or 12: Approximately 18 working days
    • LucenceINSIGHT™ 50: Approximately 12 working days

    Once the results are ready, your doctor will review them with you during the follow-up consultation.